A new approach to prostate cancer screening

Area of Science:

• Urology
• Oncology
• Public Health

Background:

• Prostate-specific antigen (PSA) testing for prostate cancer screening has been controversial due to effective mortality reduction but also overdiagnosis and overtreatment.
• Restrictive recommendations from scientific societies have emerged, creating a debate between widespread screening and no screening.
• Recent years have seen proposals for new screening approaches to improve the benefit/risk balance of PSA testing.

Purpose of the Study:

• To address the controversy surrounding prostate cancer screening.
• To propose and evaluate new screening strategies that reconsider PSA testing.
• To establish a favorable benefit/risk balance for prostate cancer screening.

Main Methods:

• Reviewing existing prostate cancer screening protocols and their outcomes.
• Developing novel screening approaches based on baseline PSA concentrations.
• Integrating magnetic resonance imaging (MRI) with PSA testing for enhanced accuracy.

Main Results:

• The European Association of Urology proposed a screening strategy based on baseline PSA levels.
• The European Commission recommended organized screening programs for men up to 70 years.
• The recommended approach combines PSA values with follow-up MRI.

Conclusions:

• Organized prostate cancer screening programs incorporating PSA testing and MRI offer a promising solution to the screening controversy.
• These programs aim to optimize the balance between detecting prostate cancer and avoiding unnecessary interventions.
• The implementation of these programs represents a significant step towards evidence-based prostate cancer screening.